OxyContin-Maker Purdue Pharma Launched A Stealth Campaign To Sway U.S. Officials
With a federal judge poised to approve Purdue Pharma's controversial Chapter 11 plan, the company is working behind the scenes to preempt a legal challenge by the DOJ.